The jump from 1mg to 4mg produced nearly double the weight loss, from 8.7% to 17.1%, suggesting that the glucagon component only becomes meaningfully active somewhere in that dose range
We built this tracker to give patients an easier way to navigate GLP-1 shortages, by: 1 Clearly showing which GLP-1s are currently in shortage by drug and dose 2 Making it easy for everyone to crowdsource where and when they find GLP-1 supply or, when they cannot, to submit a shortage report to the FDA 3 Letting anyone join our Supply List that sends real-time alerts when GLP-1 supply is located at a pharmacy near them 4 Sending automated notifications to patients and providers who sign-up letting them know when a drugs status changes on the FDAs list
When to seek urgent medical advice : Sudden worsening of joint pain, swelling, or stiffness Signs of infection (fever, malaise, localised warmth) Severe abdominal pain (potential pancreatitis if on GLP-1 therapy) Unexplained persistent nausea or vomiting Any concerning new symptoms after starting any new medication According to NICE Quality Standard 33, if you have suspected persistent synovitis, you should be referred to rheumatology within 3 working days and assessed within 3 weeks
For the Media Please cite this data as National Poison Data System, Americas Poison Centers. Any and all print, digital, social, or visual media using this data must include the following: You can reach your local poison center by calling Poison Help at 1-800-222-1222
I also bone pressed during measurement before and also this time
Never disregard professional medical advice or delay seeking care because of something you read in this newsletter
